 | • レポートコード：MRC2-11QY00914 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はデング熱ワクチンのグローバル市場について調査・分析したレポートです。種類別（CYD-TDV、DENVax・TAK-003、TetraVax-DV、TDENV PIV、V180、DNAワクチン）市場規模、用途別（政府機関、病院、NGO）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別デング熱ワクチンの競争状況、市場シェア ・世界のデング熱ワクチン市場：種類別市場規模 2015年-2020年（CYD-TDV、DENVax・TAK-003、TetraVax-DV、TDENV PIV、V180、DNAワクチン） ・世界のデング熱ワクチン市場：種類別市場規模予測 2021年-2026年（CYD-TDV、DENVax・TAK-003、TetraVax-DV、TDENV PIV、V180、DNAワクチン） ・世界のデング熱ワクチン市場：用途別市場規模 2015年-2020年（政府機関、病院、NGO） ・世界のデング熱ワクチン市場：用途別市場規模予測 2021年-2026年（政府機関、病院、NGO） ・北米のデング熱ワクチン市場分析：米国、カナダ ・ヨーロッパのデング熱ワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのデング熱ワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のデング熱ワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのデング熱ワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GlaxoSmithKline、Merck Sharp & Dohme、Sanofi、Takeda Pharmaceuticals、GeneOne Life Sciences、Medigen Biologics、Panacea Biotec、Sun Pharmaceutical、U.S NIH、Vabiotec ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The Aedes aegypti mosquito is responsible for transmitting the dengue virus (DENV). The virus that causes dengue belongs to the Flavivirus genus of the Flaviviridae family. Dengue fever resembles influenza and affects adults, children, as well as infants, but it is rarely fatal. However, dengue hemorrhagic fever is a potentially fatal complication because of multiple factors such as fluid accumulation, severe bleeding, organ impairment, or plasma leaking.
With the increasing population density and global warming, there is a rapid growth in the prevalence of dengue, especially in the tropical and subtropical regions across the world. According to the National Institute of Health, approximately 0.05 to 0.2 billion cases of dengue infections are reported annually and the mortality rate due to dengue was above 20,000. The report has identified the rapid growth in disease incidences as one of the primary factors that will fuel the growth of the dengue vaccine market in the coming years. The prevalence of dengue is present in more than 125 countries across the world and the rising prevalence of dengue will drive the market during the forecast period.
Market Analysis and Insights: Global Dengue Vaccine Market
The global Dengue Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Dengue Vaccine Scope and Market Size
Dengue Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dengue Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Dengue Vaccine market is segmented into
CYD-TDV
DENVax or TAK-003
TetraVax-DV
TDENV PIV
V180
DNA vaccines
Segment by Application, the Dengue Vaccine market is segmented into
Government institutions
Hospitals
NGOs
Regional and Country-level Analysis
The Dengue Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Dengue Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Dengue Vaccine Market Share Analysis
Dengue Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Dengue Vaccine business, the date to enter into the Dengue Vaccine market, Dengue Vaccine product introduction, recent developments, etc.
The major vendors covered:
GlaxoSmithKline
Merck Sharp & Dohme
Sanofi
Takeda Pharmaceuticals
GeneOne Life Sciences
Medigen Biologics
Panacea Biotec
Sun Pharmaceutical
U.S NIH
Vabiotec
1 Study Coverage
1.1 Dengue Vaccine Product Introduction
1.2 Market Segments
1.3 Key Dengue Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Dengue Vaccine Market Size Growth Rate by Type
1.4.2 CYD-TDV
1.4.3 DENVax or TAK-003
1.4.4 TetraVax-DV
1.4.5 TDENV PIV
1.4.6 V180
1.4.7 DNA vaccines
1.5 Market by Application
1.5.1 Global Dengue Vaccine Market Size Growth Rate by Application
1.5.2 Government institutions
1.5.3 Hospitals
1.5.4 NGOs
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Dengue Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Dengue Vaccine Revenue 2015-2026
2.1.2 Global Dengue Vaccine Sales 2015-2026
2.2 Global Dengue Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Dengue Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Dengue Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Dengue Vaccine Competitor Landscape by Players
3.1 Dengue Vaccine Sales by Manufacturers
3.1.1 Dengue Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Dengue Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Dengue Vaccine Revenue by Manufacturers
3.2.1 Dengue Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Dengue Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Dengue Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Dengue Vaccine Revenue in 2019
3.2.5 Global Dengue Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Dengue Vaccine Price by Manufacturers
3.4 Dengue Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Dengue Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dengue Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Dengue Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Dengue Vaccine Market Size by Type (2015-2020)
4.1.1 Global Dengue Vaccine Sales by Type (2015-2020)
4.1.2 Global Dengue Vaccine Revenue by Type (2015-2020)
4.1.3 Dengue Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Dengue Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Dengue Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Dengue Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Dengue Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Dengue Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Dengue Vaccine Market Size by Application (2015-2020)
5.1.1 Global Dengue Vaccine Sales by Application (2015-2020)
5.1.2 Global Dengue Vaccine Revenue by Application (2015-2020)
5.1.3 Dengue Vaccine Price by Application (2015-2020)
5.2 Dengue Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Dengue Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Dengue Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Dengue Vaccine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Dengue Vaccine by Country
6.1.1 North America Dengue Vaccine Sales by Country
6.1.2 North America Dengue Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Dengue Vaccine Market Facts & Figures by Type
6.3 North America Dengue Vaccine Market Facts & Figures by Application
7 Europe
7.1 Europe Dengue Vaccine by Country
7.1.1 Europe Dengue Vaccine Sales by Country
7.1.2 Europe Dengue Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Dengue Vaccine Market Facts & Figures by Type
7.3 Europe Dengue Vaccine Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Dengue Vaccine by Region
8.1.1 Asia Pacific Dengue Vaccine Sales by Region
8.1.2 Asia Pacific Dengue Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Dengue Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Dengue Vaccine Market Facts & Figures by Application
9 Latin America
9.1 Latin America Dengue Vaccine by Country
9.1.1 Latin America Dengue Vaccine Sales by Country
9.1.2 Latin America Dengue Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Dengue Vaccine Market Facts & Figures by Type
9.3 Central & South America Dengue Vaccine Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Dengue Vaccine by Country
10.1.1 Middle East and Africa Dengue Vaccine Sales by Country
10.1.2 Middle East and Africa Dengue Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Dengue Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Dengue Vaccine Market Facts & Figures by Application
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description and Business Overview
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Dengue Vaccine Products Offered
11.1.5 GlaxoSmithKline Related Developments
11.2 Merck Sharp & Dohme
11.2.1 Merck Sharp & Dohme Corporation Information
11.2.2 Merck Sharp & Dohme Description and Business Overview
11.2.3 Merck Sharp & Dohme Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck Sharp & Dohme Dengue Vaccine Products Offered
11.2.5 Merck Sharp & Dohme Related Developments
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Description and Business Overview
11.3.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sanofi Dengue Vaccine Products Offered
11.3.5 Sanofi Related Developments
11.4 Takeda Pharmaceuticals
11.4.1 Takeda Pharmaceuticals Corporation Information
11.4.2 Takeda Pharmaceuticals Description and Business Overview
11.4.3 Takeda Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Takeda Pharmaceuticals Dengue Vaccine Products Offered
11.4.5 Takeda Pharmaceuticals Related Developments
11.5 GeneOne Life Sciences
11.5.1 GeneOne Life Sciences Corporation Information
11.5.2 GeneOne Life Sciences Description and Business Overview
11.5.3 GeneOne Life Sciences Sales, Revenue and Gross Margin (2015-2020)
11.5.4 GeneOne Life Sciences Dengue Vaccine Products Offered
11.5.5 GeneOne Life Sciences Related Developments
11.6 Medigen Biologics
11.6.1 Medigen Biologics Corporation Information
11.6.2 Medigen Biologics Description and Business Overview
11.6.3 Medigen Biologics Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Medigen Biologics Dengue Vaccine Products Offered
11.6.5 Medigen Biologics Related Developments
11.7 Panacea Biotec
11.7.1 Panacea Biotec Corporation Information
11.7.2 Panacea Biotec Description and Business Overview
11.7.3 Panacea Biotec Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Panacea Biotec Dengue Vaccine Products Offered
11.7.5 Panacea Biotec Related Developments
11.8 Sun Pharmaceutical
11.8.1 Sun Pharmaceutical Corporation Information
11.8.2 Sun Pharmaceutical Description and Business Overview
11.8.3 Sun Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sun Pharmaceutical Dengue Vaccine Products Offered
11.8.5 Sun Pharmaceutical Related Developments
11.9 U.S NIH
11.9.1 U.S NIH Corporation Information
11.9.2 U.S NIH Description and Business Overview
11.9.3 U.S NIH Sales, Revenue and Gross Margin (2015-2020)
11.9.4 U.S NIH Dengue Vaccine Products Offered
11.9.5 U.S NIH Related Developments
11.10 Vabiotec
11.10.1 Vabiotec Corporation Information
11.10.2 Vabiotec Description and Business Overview
11.10.3 Vabiotec Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Vabiotec Dengue Vaccine Products Offered
11.10.5 Vabiotec Related Developments
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description and Business Overview
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Dengue Vaccine Products Offered
11.1.5 GlaxoSmithKline Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Dengue Vaccine Market Estimates and Projections by Region
12.1.1 Global Dengue Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Dengue Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Dengue Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Dengue Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Dengue Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Dengue Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Dengue Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Dengue Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Dengue Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Dengue Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Dengue Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Dengue Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Dengue Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Dengue Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Dengue Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Dengue Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Dengue Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Dengue Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Dengue Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Dengue Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Dengue Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Dengue Vaccine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Dengue Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Dengue Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Dengue Vaccine Market Segments
Table 2. Ranking of Global Top Dengue Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Dengue Vaccine Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of CYD-TDV
Table 5. Major Manufacturers of DENVax or TAK-003
Table 6. Major Manufacturers of TetraVax-DV
Table 7. Major Manufacturers of TDENV PIV
Table 8. Major Manufacturers of V180
Table 9. Major Manufacturers of DNA vaccines
Table 10. Global Dengue Vaccine Market Size Growth Rate by Application 2020-2026 (K Units)
Table 11. Global Dengue Vaccine Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 12. Global Dengue Vaccine Sales by Regions 2015-2020 (K Units)
Table 13. Global Dengue Vaccine Sales Market Share by Regions (2015-2020)
Table 14. Global Dengue Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Dengue Vaccine Sales by Manufacturers (2015-2020) (K Units)
Table 16. Global Dengue Vaccine Sales Share by Manufacturers (2015-2020)
Table 17. Global Dengue Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Dengue Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dengue Vaccine as of 2019)
Table 19. Dengue Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Dengue Vaccine Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Dengue Vaccine Price (2015-2020) (USD/Unit)
Table 22. Dengue Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Dengue Vaccine Product Type
Table 24. Date of International Manufacturers Enter into Dengue Vaccine Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Dengue Vaccine Sales by Type (2015-2020) (K Units)
Table 27. Global Dengue Vaccine Sales Share by Type (2015-2020)
Table 28. Global Dengue Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Dengue Vaccine Revenue Share by Type (2015-2020)
Table 30. Dengue Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 31. Global Dengue Vaccine Sales by Application (2015-2020) (K Units)
Table 32. Global Dengue Vaccine Sales Share by Application (2015-2020)
Table 33. North America Dengue Vaccine Sales by Country (2015-2020) (K Units)
Table 34. North America Dengue Vaccine Sales Market Share by Country (2015-2020)
Table 35. North America Dengue Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Dengue Vaccine Revenue Market Share by Country (2015-2020)
Table 37. North America Dengue Vaccine Sales by Type (2015-2020) (K Units)
Table 38. North America Dengue Vaccine Sales Market Share by Type (2015-2020)
Table 39. North America Dengue Vaccine Sales by Application (2015-2020) (K Units)
Table 40. North America Dengue Vaccine Sales Market Share by Application (2015-2020)
Table 41. Europe Dengue Vaccine Sales by Country (2015-2020) (K Units)
Table 42. Europe Dengue Vaccine Sales Market Share by Country (2015-2020)
Table 43. Europe Dengue Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Dengue Vaccine Revenue Market Share by Country (2015-2020)
Table 45. Europe Dengue Vaccine Sales by Type (2015-2020) (K Units)
Table 46. Europe Dengue Vaccine Sales Market Share by Type (2015-2020)
Table 47. Europe Dengue Vaccine Sales by Application (2015-2020) (K Units)
Table 48. Europe Dengue Vaccine Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Dengue Vaccine Sales by Region (2015-2020) (K Units)
Table 50. Asia Pacific Dengue Vaccine Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Dengue Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Dengue Vaccine Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Dengue Vaccine Sales by Type (2015-2020) (K Units)
Table 54. Asia Pacific Dengue Vaccine Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Dengue Vaccine Sales by Application (2015-2020) (K Units)
Table 56. Asia Pacific Dengue Vaccine Sales Market Share by Application (2015-2020)
Table 57. Latin America Dengue Vaccine Sales by Country (2015-2020) (K Units)
Table 58. Latin America Dengue Vaccine Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Dengue Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Dengue Vaccine Revenue Market Share by Country (2015-2020)
Table 61. Latin America Dengue Vaccine Sales by Type (2015-2020) (K Units)
Table 62. Latin America Dengue Vaccine Sales Market Share by Type (2015-2020)
Table 63. Latin America Dengue Vaccine Sales by Application (2015-2020) (K Units)
Table 64. Latin America Dengue Vaccine Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Dengue Vaccine Sales by Country (2015-2020) (K Units)
Table 66. Middle East and Africa Dengue Vaccine Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Dengue Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Dengue Vaccine Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Dengue Vaccine Sales by Type (2015-2020) (K Units)
Table 70. Middle East and Africa Dengue Vaccine Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Dengue Vaccine Sales by Application (2015-2020) (K Units)
Table 72. Middle East and Africa Dengue Vaccine Sales Market Share by Application (2015-2020)
Table 73. GlaxoSmithKline Corporation Information
Table 74. GlaxoSmithKline Description and Major Businesses
Table 75. GlaxoSmithKline Dengue Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. GlaxoSmithKline Product
Table 77. GlaxoSmithKline Recent Development
Table 78. Merck Sharp & Dohme Corporation Information
Table 79. Merck Sharp & Dohme Description and Major Businesses
Table 80. Merck Sharp & Dohme Dengue Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Merck Sharp & Dohme Product
Table 82. Merck Sharp & Dohme Recent Development
Table 83. Sanofi Corporation Information
Table 84. Sanofi Description and Major Businesses
Table 85. Sanofi Dengue Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Sanofi Product
Table 87. Sanofi Recent Development
Table 88. Takeda Pharmaceuticals Corporation Information
Table 89. Takeda Pharmaceuticals Description and Major Businesses
Table 90. Takeda Pharmaceuticals Dengue Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Takeda Pharmaceuticals Product
Table 92. Takeda Pharmaceuticals Recent Development
Table 93. GeneOne Life Sciences Corporation Information
Table 94. GeneOne Life Sciences Description and Major Businesses
Table 95. GeneOne Life Sciences Dengue Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. GeneOne Life Sciences Product
Table 97. GeneOne Life Sciences Recent Development
Table 98. Medigen Biologics Corporation Information
Table 99. Medigen Biologics Description and Major Businesses
Table 100. Medigen Biologics Dengue Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Medigen Biologics Product
Table 102. Medigen Biologics Recent Development
Table 103. Panacea Biotec Corporation Information
Table 104. Panacea Biotec Description and Major Businesses
Table 105. Panacea Biotec Dengue Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Panacea Biotec Product
Table 107. Panacea Biotec Recent Development
Table 108. Sun Pharmaceutical Corporation Information
Table 109. Sun Pharmaceutical Description and Major Businesses
Table 110. Sun Pharmaceutical Dengue Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Sun Pharmaceutical Product
Table 112. Sun Pharmaceutical Recent Development
Table 113. U.S NIH Corporation Information
Table 114. U.S NIH Description and Major Businesses
Table 115. U.S NIH Dengue Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. U.S NIH Product
Table 117. U.S NIH Recent Development
Table 118. Vabiotec Corporation Information
Table 119. Vabiotec Description and Major Businesses
Table 120. Vabiotec Dengue Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. Vabiotec Product
Table 122. Vabiotec Recent Development
Table 123. Global Dengue Vaccine Sales Forecast by Regions (2021-2026) (K Units)
Table 124. Global Dengue Vaccine Sales Market Share Forecast by Regions (2021-2026)
Table 125. Global Dengue Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 126. Global Dengue Vaccine Revenue Market Share Forecast by Regions (2021-2026)
Table 127. North America: Dengue Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 128. North America: Dengue Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Europe: Dengue Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 130. Europe: Dengue Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Asia Pacific: Dengue Vaccine Sales Forecast by Region (2021-2026) (K Units)
Table 132. Asia Pacific: Dengue Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 133. Latin America: Dengue Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 134. Latin America: Dengue Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Middle East and Africa: Dengue Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 136. Middle East and Africa: Dengue Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 138. Key Challenges
Table 139. Market Risks
Table 140. Main Points Interviewed from Key Dengue Vaccine Players
Table 141. Dengue Vaccine Customers List
Table 142. Dengue Vaccine Distributors List
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Dengue Vaccine Product Picture
Figure 2. Global Dengue Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. CYD-TDV Product Picture
Figure 4. DENVax or TAK-003 Product Picture
Figure 5. TetraVax-DV Product Picture
Figure 6. TDENV PIV Product Picture
Figure 7. V180 Product Picture
Figure 8. DNA vaccines Product Picture
Figure 9. Global Dengue Vaccine Sales Market Share by Application in 2020 & 2026
Figure 10. Government institutions
Figure 11. Hospitals
Figure 12. NGOs
Figure 13. Dengue Vaccine Report Years Considered
Figure 14. Global Dengue Vaccine Market Size 2015-2026 (US$ Million)
Figure 15. Global Dengue Vaccine Sales 2015-2026 (K Units)
Figure 16. Global Dengue Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Dengue Vaccine Sales Market Share by Region (2015-2020)
Figure 18. Global Dengue Vaccine Sales Market Share by Region in 2019
Figure 19. Global Dengue Vaccine Revenue Market Share by Region (2015-2020)
Figure 20. Global Dengue Vaccine Revenue Market Share by Region in 2019
Figure 21. Global Dengue Vaccine Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Dengue Vaccine Revenue in 2019
Figure 23. Dengue Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Dengue Vaccine Sales Market Share by Type (2015-2020)
Figure 25. Global Dengue Vaccine Sales Market Share by Type in 2019
Figure 26. Global Dengue Vaccine Revenue Market Share by Type (2015-2020)
Figure 27. Global Dengue Vaccine Revenue Market Share by Type in 2019
Figure 28. Global Dengue Vaccine Market Share by Price Range (2015-2020)
Figure 29. Global Dengue Vaccine Sales Market Share by Application (2015-2020)
Figure 30. Global Dengue Vaccine Sales Market Share by Application in 2019
Figure 31. Global Dengue Vaccine Revenue Market Share by Application (2015-2020)
Figure 32. Global Dengue Vaccine Revenue Market Share by Application in 2019
Figure 33. North America Dengue Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 34. North America Dengue Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Dengue Vaccine Sales Market Share by Country in 2019
Figure 36. North America Dengue Vaccine Revenue Market Share by Country in 2019
Figure 37. U.S. Dengue Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 38. U.S. Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Dengue Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 40. Canada Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Dengue Vaccine Market Share by Type in 2019
Figure 42. North America Dengue Vaccine Market Share by Application in 2019
Figure 43. Europe Dengue Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 44. Europe Dengue Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Dengue Vaccine Sales Market Share by Country in 2019
Figure 46. Europe Dengue Vaccine Revenue Market Share by Country in 2019
Figure 47. Germany Dengue Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 48. Germany Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Dengue Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 50. France Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Dengue Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 52. U.K. Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Dengue Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 54. Italy Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Dengue Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 56. Russia Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Dengue Vaccine Market Share by Type in 2019
Figure 58. Europe Dengue Vaccine Market Share by Application in 2019
Figure 59. Asia Pacific Dengue Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 60. Asia Pacific Dengue Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Dengue Vaccine Sales Market Share by Region in 2019
Figure 62. Asia Pacific Dengue Vaccine Revenue Market Share by Region in 2019
Figure 63. China Dengue Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 64. China Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Dengue Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 66. Japan Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Dengue Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 68. South Korea Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Dengue Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 70. India Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Dengue Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 72. Australia Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Dengue Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 74. Taiwan Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Dengue Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 76. Indonesia Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Dengue Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 78. Thailand Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Dengue Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 80. Malaysia Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Dengue Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 82. Philippines Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Dengue Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 84. Vietnam Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Dengue Vaccine Market Share by Type in 2019
Figure 86. Asia Pacific Dengue Vaccine Market Share by Application in 2019
Figure 87. Latin America Dengue Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 88. Latin America Dengue Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Dengue Vaccine Sales Market Share by Country in 2019
Figure 90. Latin America Dengue Vaccine Revenue Market Share by Country in 2019
Figure 91. Mexico Dengue Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 92. Mexico Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Dengue Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 94. Brazil Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Dengue Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 96. Argentina Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Dengue Vaccine Market Share by Type in 2019
Figure 98. Latin America Dengue Vaccine Market Share by Application in 2019
Figure 99. Middle East and Africa Dengue Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 100. Middle East and Africa Dengue Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Dengue Vaccine Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Dengue Vaccine Revenue Market Share by Country in 2019
Figure 103. Turkey Dengue Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 104. Turkey Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Dengue Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 106. Saudi Arabia Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Dengue Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 108. U.A.E Dengue Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Dengue Vaccine Market Share by Type in 2019
Figure 110. Middle East and Africa Dengue Vaccine Market Share by Application in 2019
Figure 111. North America Dengue Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. North America Dengue Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Dengue Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Europe Dengue Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Dengue Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Asia Pacific Dengue Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Dengue Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Latin America Dengue Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Dengue Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. Middle East and Africa Dengue Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
デング熱検査の世界市場（～2026年） The number of cases of dengue are growing rapidly during the past few years. Major regions of the world that are affected by dengue are Africa, the Americas, the Eastern Mediterranean, Southeast Asia and the Western Pacific. As per the numbers provided by WHO, the number of reported cases is continu…- 結核ワクチン治療の世界市場（～2026年） Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at …
- 動物用ワクチンの世界市場（～2026年） Animal Vaccine is the administration of antigenic material (a vaccine) to stimulate an individual's immune system to develop adaptive immunity to a pathogen. The major factors driving the growth of this market include growth in livestock population and repeated breakouts of livestock diseases; incre…
- 子宮頸がんワクチンの世界市場（～2026年） Market Analysis and Insights: Global Cervical Cancer Vaccine Market The global Cervical Cancer Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cervical Cancer Vaccine Scope and Market Size Cervical Cancer Vacci…
- アデノウイルスワクチンの世界市場（～2026年） Market Analysis and Insights: Global Adenovirus Vaccine Market The global Adenovirus Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Adenovirus Vaccine Scope and Market Size Adenovirus Vaccine market is segment…